| |transkript [Kääb, Georg]. (9/24/24). "First German Life Sciences IPO since 2016 – Radiopharma Company Pentixapharm Lists at Frankfurt Stock Exchange. Interview by |transkript.de/Georg Kääb with Andreas Eckert". |
2024-09-24 |
| [iito] Business Intelligence. (May 2019). "Special Feature: What Does [iito] Stand For? A Powerful Business Database System, based on Property Rights Theory and Institutional Economics = [i]nstitutions [i]nformation [t]echnologies [o]rganisation!". Breme |
2019-05-30 |
| [iito] Business Intelligence. (April 2019). "Special Feature: [iito] Relaunches Life-Sciences-UK.com & Life-Sciences-France.com". Bremen. |
2019-04-17 |
| [iito] Business Intelligence. (April 2019). "Special Feature: [iito] Reaches New Milestone – Now more than 9,900 European Life Science Deals Available at Life-Sciences-Europe.com". Bremen. |
2019-04-26 |
| [iito] Business Intelligence. (7/8/19). "Press Release: [iito] Launches Life-Sciences-Benelux.com
& Life-Sciences-Scandinavia.com". Bremen. |
2019-07-08 |
| [iito] Business Intelligence. (7/15/20). "Press Release: [iito] Launches ADucation Campaign Summer 2020". Bremen. |
2020-07-15 |
| [iito] Business Intelligence. (7/1/19). "Press Release: Worldwide First! [iito] Does Away with All Tracking Cookies and Third Party Cookies". Bremen. |
2019-07-01 |
| [iito] Business Intelligence. (5/4/20). "Press Release: [iito] Brings Back the Past into the [LSE] Newsletter". Bremen. |
2020-05-04 |
| [iito] Business Intelligence. (12/10/20). "The [LSE] Newsletter Is Out! Hand-picked & Manually Edited European and Israeli Life Science Business News". Bremen. |
2020-12-10 |
| [iito] Business Intelligence. (11/8/20). "The [LSUS] Newsletter Is Out! Hand-picked & Manually Edited Transatlantic Life Science Business News from Europe and North America". Bremen. |
2020-11-08 |
| [iito] Business Intelligence. (11/30/20). "The [LSG] Newsletter Is Out! Hand-picked & Manually Edited DACH Region Life Science Business News from Germany, Austria & Switzerland". Bremen. |
2020-11-30 |
| [iito] Business Intelligence. (11/11/19). "Press Release: [iito] Launches Transatlantic Life Sciences Business Portal at BIO-Europe". Bremen & Hamburg. |
2019-11-11 |
| [iito] Business Intelligence. (1/11/19). "Press Release: [iito] Discontinues Life-Sciences-UK.com
and Life-Sciences-France.com. All Data Will Still Be Available at Life-Sciences-Europe.com". Bremen. |
2019-01-11 |
| Zur Rose Group AG. (7/16/20). "Press Release: Zur Rose Group Acquires TeleClinic, Germany's Leading Telemedicine Provider". |
2020-07-16 |
| Zogenix, Inc.. (3/6/20). "Press Release: Zogenix Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares". Emeryville, CA. |
2020-03-06 |
| Ziphius Vaccines N.V.. (6/9/22). "Press Release: Ziphius Vaccines and University of Antwerp Announce Collaboration Agreement for Optimized Delivery of saRNA-based Vaccines & Therapeutics". |
2022-06-09 |
| Ziphius Vaccines N.V.. (5/25/21). "Press Release: Ziphius Vaccines Raises €29.3M in Oversubscribed Series A Financing". |
2021-05-25 |
| Zion Pharma Ltd.. (5/9/23). "Press Release: Zion Pharma Announces Global Agreement with Roche to Develop and Commercialize a Blood Brain Barrier Penetrant Oral HER2 Tyrosine Kinase Inhibitor". Hong Kong, Suzhou & Shanghai. |
2023-05-09 |
| Zhejiang Doer Biologics Co., Ltd.. (7/10/23). "Press Release: Doer Biologics Announces License Agreement with BioNTech". Hangzhou. |
2023-07-10 |
| Zetta Genomics Ltd.. (7/5/23). "Press Release: Zetta Genomics Appoints First Chief Revenue Officer". |
2023-07-05 |
| Zetta Genomics Ltd.. (4/18/23). "Press Release: Zetta Genomics Secures £1.9 Million in Second Round Seed Funding to Configure for Scale, Delivery and Innovation". |
2023-04-18 |
| Zetta Genomics Ltd.. (2/8/24). "Press Release: Zetta Genomics Expands Second Seed Funding Round with Additional £1.8 Million". |
2024-02-08 |
| Zetta Genomics Ltd.. (2/1/22). "Press Release: Zetta Genomics Gains £2.5m Seed Funding to Realise the Power of Genomic Data in Precision Medicine". New York, NY. |
2022-02-01 |
| Zelluna Immunotherapy AS. (8/19/21). "Press Release: Exclusive License Agreement with the U.S. National Cancer Institute to Develop and Commercialize KK-LC-1 Targeting Allogeneic »Off-the-Shelf« TCR Based Natural Killer (TCR-NK) Cell Therapies". Oslo. |
2021-08-19 |
| Zelluna Immunotherapy AS. (6/25/19). "Press Release: Zelluna Immunotherapy Appoints Jens-Peter Marschner as Chief Medical Officer". Oslo. |
2019-06-25 |
| Zelluna Immunotherapy AS. (6/11/20). "Press Release: Zelluna Immunotherapy Raises Funds to Fully Focus on Developing Allogeneic “Off-the-Shelf” TCR based Natural Killer (TCR-NK) Cell Therapies". Oslo. |
2020-06-11 |
| Zelluna Immunotherapy AS. (12/19/19). "Press Release: Zelluna Immunotherapy Appoints Namir Hassan as Chief Executive Officer". Oslo. |
2019-12-19 |
| Zelluna Immunotherapy AS. (11/4/19). "Press Release: Zelluna Immunotherapy Appoints Dr Bent Jakobsen, a Pioneer of TCR Therapeutics, to the Board of Directors". Oslo. |
2019-11-04 |
| Zelluna Immunotherapy AS. (11/19/19). "Press Release: Zelluna Immunotherapy and Glycostem Therapeutics Announce Partnership to Develop Allogeneic TCR-NK Therapies". Oslo & Oss. |
2019-11-19 |
| Zealand Pharma A/S. (9/24/19). "Press Release: Zealand Pharma Achieves Primary and All Key Secondary Endpoints in Pediatric Phase 3 Trial with Dasiglucagon for Severe Hypoglycemia". Copenhagen. |
2019-09-24 |
| Zealand Pharma A/S. (3/30/22). "Press Release: Zealand Pharma Appoints New Chief Executive Officer, Refocuses Strategy to Prioritize Research & Development and Streamlines Operations". Copenhagen & Boston, MA. |
2022-03-30 |
| Zealand Pharma A/S. (10/22/19). "Press Release: Zealand Pharma Expands Its Peptide Platform with Acquisition of Encycle Therapeutics". Copenhagen. |
2019-10-22 |
| ZAR Real Estate Holding GmbH & Co. KG. (4/5/24). "Press Release: Positive Preliminary Building Permit for “Life Science Campus” in Dusseldorf". Düsseldorf. |
2024-04-05 |
| Zambon Group. (7/25/19). "Press Release: Zambon Completes Transformational Acquisition of Breath Therapeutics". Milan. |
2019-07-25 |
| Zafrens. (12/11/23). "Press Release: Zafrens Launches with $23M in Financing to Advance Multiple Stages of Drug Discovery in a Single Experiment at Unprecedented Scale". San Diego, CA. |
2023-12-11 |
| Yumab GmbH. (7/22/19). "Press Release: Yumab Announces New Research and Collaboration Agreement with Merck". Braunschweig. |
2019-07-22 |
| Yumab GmbH. (7/19/23). "Press Release: Yumab and InScreeneX in Joint Funding Project". Braunschweig. |
2023-07-19 |
| Yumab GmbH. (6/16/20). "Press Release: Corat Therapeutics Takes Over the Fast Track Development of a Novel COVID-19 Antibody Drug Program". Braunschweig. |
2020-06-16 |
| Yumab GmbH. (5/7/20). "Press Release: Yumab Identifies Promising Candidate for Covid-19 Antibody Therapy". Braunschweig. |
2020-05-07 |
| Yukin Therapeutics SAS. (6/4/19). "Press Release: Yukin Therapeutics Raises €3.3 million to Develop New Cancer Treatments". Sophia Antipolis. |
2019-06-04 |
| Ysios Capital. (6/10/20). "Press Release: Ysios Capital Presents Its Third Fund of € 200M". San Sebastián & Barcelona. |
2020-06-10 |
| Ysios Capital. (3/4/22). "Press Release: Ysios Capital Strengthens Its Team with the Appointment of Thomas Harth as Principal
Thomas Harth". San Sebastián & Barcelona. |
2022-03-04 |
| Ysios Capital. (1/19/23). "Press Release: Ysios Capital Strengthens Its Team with Internal Promotions and a New Venture Partner". San Sebastián & Barcelona. |
2023-01-19 |
| Yposkesi. (6/5/19). "Press Release: Servier Appoints Yposkesi for Lentiviral Vector GMP-Manufacturing in CAR-T Cell Development Technology". Suresnes & Corbeil-Essonnes. |
2019-06-05 |
| Yposkesi. (2/28/22). "Press Release: Yposkesi, an SK pharmteco Company, Appoints US-based Executive Director for Business Development". Corbeil-Essonnes. |
2022-02-28 |
| Yposkesi. (2/24/20). "Press Release: Yposkesi Welcomes Patrick Lansky as VP of US Sales & Marketing". Corbeil-Essonnes. |
2020-02-24 |
| Yokogawa Electric Corporation. (11/2/21). "Press Release: Yokogawa Acquires Insilico Biotechnology, Developer of Innovative Bioprocess Digital Twin Technology". Tokyo. |
2021-11-02 |
| Ynsect SAS. (10/6/20). "Press Release: Agtech Startup Ÿnsect Extends Its Series C to $372 Million to Improve Global Food Security and Sustainability with the First Carbon Negative and Largest Vertical Farm in the World". Paris. |
2020-10-06 |
| Ynsect S.A.. (2/21/19). "Press Release: Ÿnsect Raises $125m to Become World Leader in Alternative Protein". Paris & London. |
2019-02-21 |
| Ymmunobio AG. (6/16/22). "Press Release: Ymmunobio Signs Collaboration Agreement with Yumab". Riehen. |
2022-06-16 |
| Ygion Biomedical GmbH. (5/21/24). "Press Release: Ygion Biomedical Announces €15 Million Series A Financing to Develop Individualized Cancer Immunotherapies". |
2024-05-21 |
| Xund Solutions GmbH. (9/29/22). "Press Release: Healthtech Start-up Xund Raises €6m – One of the Largest Seed Rounds to Date in Austria". |
2022-09-29 |
| XPhyto Therapeutics Corporation. (7/20/21). "Press Release: XPhyto Signs Transformative Acquisition Agreement with 3a-Diagnostics, to Enter Hi-tech Biosensor Market and Expand Its Diagnostic Product Portfolio". Vancouver, BC & Frankfurt. |
2021-07-20 |
| XO Life GmbH. (2/16/22). "Press Release: Two Million Euros for XO Life GmbH’s Patient Insights Platform". Berlin & Munich. |
2022-02-16 |
| XNK Therapeutics AB. (3/29/22). "Press Release: XNK Therapeutics Raises SEK 132 Million to Accelerate Growth". |
2022-03-29 |
| Xlife Sciences AG. (12/1/21). "Press Release: Xlife Sciences AG (XLS DE) Appoints New Chief Financial Officer". Zürich. |
2021-12-01 |
| Xlife Sciences AG. (11/4/19). "Press Release: Xlife Siences AG. New Project in the Portfolio". Zurich. |
2019-11-04 |
| Xlife Sciences AG. (11/21/22). "Press Release: Xlife Sciences Initiates a Review of Strategic Options". Zürich. |
2022-11-21 |
| Xlife Sciences AG. (1/10/22). "Press Release: Xlife Sciences Plans Listing on the »Sparks« Segment of SIX Swiss Exchange". Zürich. |
2022-01-10 |
| Xenothera. (6/29/21). "Press Release: French Biotech Xenothera Accelerates Its Development with Fundraising of 20 Million Euros". Nantes. |
2021-06-29 |
| Xencor, Inc.. (2/5/19). "Press Release: Xencor to Develop and Commercialize Novel IL-15 Immune Activating Cytokines with Genentech". Monrovia, CA. |
2019-02-05 |
| Xencor, Inc.. (1/7/19). "Press Release: Xencor Regains ex-U.S. Commercial Rights to XmAb13676, CD20 x CD3 Bispecific Antibody". Monrovia, CA. |
2019-01-07 |
| XAnge (Alexis du Peloux). (3/29/22). "Press Release (Blog Post): Core Biogenesis – When a Deeptech Goes Faster than Eexpected, Let’s Speed Up!". |
2022-03-29 |
| X-Chem, Inc.. (6/20/24). "Press Release: X-Chem Strengthens Its Data-Driven Discovery Services with New CBO Appointment". Watertown, MA. |
2024-06-20 |
| X-Biotix Therapeutics, Inc.. (7/1/19). "Press Release: X-Biotix Therapeutics Joins Antimicrobials Working Group". Washington, DC. |
2019-07-01 |
| WuXi Biologics. (1/11/24). "Press Release: WuXi Biologics Announces Research Service Agreement with BioNTech on Discovering Investigational Monoclonal Antibodies for Developing Next-Generation Therapeutic Product Candidates". Shanghai. |
2024-01-11 |
| Wren Therapeutics Ltd.. (1/22/19). "Press Release: Wren Therapeutics Completes £18 Million Series A Financing". Cambridge. |
2019-01-22 |
| WMT AG. (11/28/23). "Press Release: FS Investment Acquires a Stake in WMT AG". Düsseldorf & Heidelberg. |
2023-11-28 |
| WhiteLab Genomics. (5/6/24). "Press Release: WhiteLab Genomics Establishes US Presence by Securing Spot at Bayer Co.Lab and Ginkgo Bioworks’ Technology Network". Cambridge, MA. |
2024-05-06 |
| Werum IT Solutions AG. (5/16/19). "Press Release: Jens Woehlbier Assigned as New CEO of Werum IT Solutions". Lüneburg. |
2019-05-16 |
| Werfen. (11/3/22). "Press Release: Werfen to Acquire Immucor, Inc., Expanding Its Presence in Specialized DiagnosticsNeurological Disorders". Barcelona. |
2022-11-03 |
| Wellington Partners. (7/31/19). "Press Release: Wellington Partners Raises EUR 210 Million Life Science Fund". |
2019-07-31 |
| Wellington Partners. (1/8/20). "Press Release: Karl Naegler Joins Wellington Partners as Managing Partner". Munich. |
2020-01-08 |
| Weezion SAS. (6/1/22). "Press Release: Weezion, a French MedTech Start-up, Announces Capital Investment from bioMérieux". Lyon. |
2022-06-01 |
| Waters Corporation. (7/15/20). "Press Release: Waters Corporation Names Udit Batra President and Chief Executive Officer. Announces Preliminary Second Quarter 2020 Sales". Milford, MA. |
2020-07-15 |
| Waters Corporation. (6/5/23). "Press Release: Waters and Sartorius Expand Collaboration to Deliver Comprehensive Bioanalytics for Downstream Biomanufacturing". Milford, MA & Göttingen. |
2023-06-05 |
| Waters Corporation. (5/16/23). "Press Release: Waters Corporation Completes Acquisition of Light Scattering Leader Wyatt Technology". Milford, MA. |
2023-05-16 |
| Waters Corporation. (2/15/23). "Press Release: Waters Corporation to Acquire Wyatt Technology, Light Scattering Instrument and Software Leader". Milford, MA. |
2023-02-15 |
| Waters Corporation. (11/7/19). "Press Release: World’s First Cyclic IMS Mass Spectrometer Installed at Aston University". Milford, MA. |
2019-11-07 |
| Waters Corporation. (11/2/20). "Press Release: Waters Gives More Laboratories Access to Mass Spectrometry with Rapid, Easy, and Compact Radian ASAP System". Milford, MA. |
2020-11-02 |
| Waters Corporation. (10/27/21). "Press Release: Waters and Sartorius Partner to Help Bioprocess Scientists Accelerate Clone Selection and Process Development". Milford, MA & Göttingen. |
2021-10-27 |
| Waters Corporation. (1/13/20). "Press Release: Waters to Acquire Andrew Alliance". Milford, MA. |
2020-01-13 |
| Warburg Pincus LLC. (2/10/22). "Press Release: Warburg Pincus Announces Acquisition Of Pharma Intelligence From Informa". |
2022-02-10 |
| Wacker Chemie AG. (7/5/22). "Press Release: Wacker to Start Construction of Competence Center for mRNA Actives at Halle Site". Tübingen & Boston, MA. |
2022-07-05 |
| Wacker Chemie AG. (7/28/20). "Press Release: Wacker Invests in Amsterdam Biotech Site". Munich & Amsterdam. |
2020-07-28 |
| Wacker Chemie AG. (6/3/24). "Press Release: Wacker Opens mRNA Competence Center in Halle an der Saale, Germany". Munich & Halle (Saale). |
2024-06-03 |
| Wacker Chemie AG. (6/2/22). "Press Release: Wacker to Invest Double-Digit Million-Euro Sum in Biotechnology Center". Munich. |
2022-06-27 |
| Wacker Chemie AG. (6/19/24). "Press Release: Wacker & CordenPharma Enter Pandemic Readiness on 1 June 2024 After Successful Expansion & Qualification". Munich, Halle (Saale) & Basel. |
2024-06-19 |
| Wacker Chemie AG. (5/8/23). "Press Release: Wacker Purchases ADL BioPharma in Spain, Strengthening Its Biotechnology Business". Munich & León. |
2023-05-08 |
| Wacker Chemie AG. (5/6/24). "Press Release: Wacker Expands Production Capacity for Biopharmaceuticals in San Diego". Munich & San Diego, CA. |
2024-05-06 |
| Wacker Chemie AG. (2/3/21). "Press Release: Wacker Strengthens Biologics Business by Acquiring US-based Plasmid DNA Manufacturer Genopis". Munich & San Diego, CA. |
2021-02-03 |
| Wacker Chemie AG. (12/8/21). "Press Release: Aleph Farms and Wacker Develop Open Supply Chain Solution for Proteins Used in Large-Scale Production of Cultivated Meat". Munich & Rehovot. |
2021-12-08 |
| Wacker Chemie AG. (12/14/21). "Press Release: Wacker and CordenPharma Develop Solutions for Formulating Lipid Nanoparticles Expanding Their Portfolio for Advanced Medicines". Munich & Luxembourg. |
2021-12-14 |
| Wacker Chemie AG. (10/12/22). "Press Release: Neuway Pharma and Wacker Launch Research Project to Develop RNA-Based Actives for the Treatment of Central Nervous System Diseases". Munich & Bonn. |
2022-10-12 |
| Wacker Chemie AG. (1/17/22). "Press Release: Plasmitec – Wacker Introduces Its Plasmid DNA Production Platform". Munich & San Diego, CA. |
2022-01-17 |
| Wacker Chemie AG. (1/11/22). "Press Release: Wacker and Biosyntia Develop Large-Scale Production Process for Sustainable Biotin". Munich & Copenhagen. |
2022-01-11 |
| Voyager Therapeutics, Inc.. (1/22/19). "Press Release: Voyager Therapeutics Appoints Robert Hesslein as General Counsel". Cambridge, MA. |
2019-01-22 |
| Vor Biopharma, Inc.. (2/14/19). "Press Release: Vor Biopharma Completes $42 Million Series A Financing Round to Advance Lead Cell Therapy Product Candidate for the Treatment of Acute Myeloid Leukemia". Boston, MA. |
2019-02-14 |
| Voluntis S.A.. (7/23/21). "Press Release: Voluntis Announces the Execution of a Share Purchase Agreement between Its Reference Shareholders and Aptar Regarding the Acquisition of a Majority Stake in Voluntis at a Price of €8.70 per Share". Cambridge, MA |
2021-07-23 |
| Voluntis S.A.. (6/22/21). "Press Release: Exclusive Negotiations Regarding a Potential Acquisition of Voluntis by Aptar to Expand in Digital Therapeutics". Cambridge, MA & Paris. |
2021-06-22 |
![[LSE] Life-Sciences-Europe.com - The European Life Sciences Web Portal](/images/basics/lse-life-sciences-europe-portal-logo.svg){kind=logo}
Source
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
